Alpha2c adrenoreceptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61P 29/00 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2620173

In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as a2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the a2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.

L'invention concerne, dans ses diverses formes d'exécution, une nouvelle classe de composés de phénylmorpholine et de phénylthiomorpholine utilisés comme agonistes du récepteur a2C adrénergique, des compositions pharmaceutiques contenant ces composés, et des procédés de traitement, de prévention, d'inhibition ou d'amélioration d'une ou de plusieurs maladies associées à des agonistes du récepteur a2C adrénergique au moyen desdits composés ou desdites compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Alpha2c adrenoreceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha2c adrenoreceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha2c adrenoreceptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1387946

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.